Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 2001-2010 of 9364

Page
per page
  1. CPI-1189
    B6109 CPI-1189
    Summary: necrosis factor (TNF) alpha inhibitor
      ≥23.4 mg/mL
  2. IMR-1
    B6110 IMR-1
    Summary: Notch pathway inhibitor
      ≥35.3 mg/mL
  3. Lu AF21934
    B6111 Lu AF21934
    Summary: positive allosteric modulator of mGlu4 receptors
      ≥31.5 mg/mL
  4. CC-115
    B6114 CC-115
    Summary: mTOR/DNA-PK inhibitor
      ≥50 mg/mL
  5. RG 13022
    B6115 RG 13022
    Summary: EGFR tyrosine kinase inhibitor
      ≥26.6 mg/mL
  6. Fluensulfone
    B6117 Fluensulfone
    Summary: new nematicide
      ≥29.2 mg/mL
  7. Dynamin inhibitory peptide
    A1046 Dynamin inhibitory peptide
    Summary: Peptide inhibitor of GTPase dynamin
      ≥112.1 mg/mL
  8. Zaragozic Acid A
    A1624 Zaragozic Acid A
    Summary: rat liver squalene synthase inhibitor
      Soluble in DMSO
  9. SR9011
    B1768 SR9011
    Summary: REV-ERB-α/β agonist
      ≥47.9 mg/mL
  10. OAC2
    A8267 OAC2
    Summary: Oct4 activator
      ≥23.6 mg/mL

Items 2001-2010 of 9364

Page
per page